Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is generated from government contracts for research and development in the United States.

http://www.achaogen.com


AKAO $0.52 -0.04 (-7.14%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 40 Million
EPS -0.92 P/E Ratio 0.00
Previous Earnings Mon, Aug 6, 2018
Latest Earnings Thu, Nov 8, 2018
Dividend --
Ex-Date --
Dividend Pay Date --
Dividend History --

0.52 0.04 0.00 0.00 AKAO NASDAQ -7.14 -58.73 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AKAO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AKAO&exchange=NASDAQ&chart=1

Symbol Surfing has been referenced on Barrons, CNN & Investor Place.

About | Blog | Advertising | Terms | info@symbolsurfing.com

Investing Quotes #Legendary


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.

©2019 Symbol Surfing All Rights Reserved. Privacy Policy | ^Top